Ingemar Qvarfordt

796 total citations
37 papers, 588 citations indexed

About

Ingemar Qvarfordt is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Physiology. According to data from OpenAlex, Ingemar Qvarfordt has authored 37 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 14 papers in Immunology and 10 papers in Physiology. Recurrent topics in Ingemar Qvarfordt's work include Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Asthma and respiratory diseases (10 papers) and Respiratory and Cough-Related Research (7 papers). Ingemar Qvarfordt is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Asthma and respiratory diseases (10 papers) and Respiratory and Cough-Related Research (7 papers). Ingemar Qvarfordt collaborates with scholars based in Sweden, United States and Australia. Ingemar Qvarfordt's co-authors include Anders Lindén, Gerdt C. Riise, Kjell Torén, Bengt Åndersson, Sven Larsson, Ingvar A. Bergdahl, Bengt Järvholm, Carina Malmhäll, Sara Tengvall and Anders Andersson and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Ingemar Qvarfordt

35 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingemar Qvarfordt Sweden 17 191 181 132 122 78 37 588
A Lindfors Sweden 15 131 0.7× 178 1.0× 107 0.8× 304 2.5× 57 0.7× 19 896
Takehito Kobayashi Japan 16 167 0.9× 167 0.9× 58 0.4× 320 2.6× 91 1.2× 56 707
Keitaro Nakamoto Japan 13 202 1.1× 117 0.6× 182 1.4× 119 1.0× 37 0.5× 63 557
Ulrika Holmlund Sweden 14 135 0.7× 348 1.9× 207 1.6× 78 0.6× 40 0.5× 21 619
Tricia Heaton Australia 10 123 0.6× 335 1.9× 118 0.9× 274 2.2× 67 0.9× 14 664
Daniel E. Dulek United States 16 111 0.6× 378 2.1× 255 1.9× 219 1.8× 28 0.4× 44 901
Huaqiong Huang China 13 110 0.6× 149 0.8× 94 0.7× 135 1.1× 29 0.4× 41 440
Brian Choo‐Kang United Kingdom 9 129 0.7× 186 1.0× 67 0.5× 111 0.9× 35 0.4× 12 483
Han‐Ki Park South Korea 16 160 0.8× 77 0.4× 55 0.4× 259 2.1× 34 0.4× 48 739
Tracy R. McMillan United States 7 138 0.7× 150 0.8× 115 0.9× 40 0.3× 21 0.3× 9 397

Countries citing papers authored by Ingemar Qvarfordt

Since Specialization
Citations

This map shows the geographic impact of Ingemar Qvarfordt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingemar Qvarfordt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingemar Qvarfordt more than expected).

Fields of papers citing papers by Ingemar Qvarfordt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingemar Qvarfordt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingemar Qvarfordt. The network helps show where Ingemar Qvarfordt may publish in the future.

Co-authorship network of co-authors of Ingemar Qvarfordt

This figure shows the co-authorship network connecting the top 25 collaborators of Ingemar Qvarfordt. A scholar is included among the top collaborators of Ingemar Qvarfordt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingemar Qvarfordt. Ingemar Qvarfordt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersson, Rune, Egil Lingaas, Ingemar Qvarfordt, & Ann Tammelin. (2025). Prevention of viral transmission must be assured before re-use of infusion sets. European Journal of Anaesthesiology. 42(3). 278–279.
2.
Paulsson, Magnus, et al.. (2023). TLR4-mediated release of heparin-binding protein in human airways: a co-stimulatory role for IL-26. Frontiers in Immunology. 14. 1178135–1178135. 1 indexed citations
3.
Paulsson, Magnus, et al.. (2022). Heparin-Binding Protein Is Increased in the Lung After Intrabronchial Endotoxin Exposure. Lund University Publications (Lund University). A2203–A2203. 1 indexed citations
4.
Kovach, Melissa A., Anders Andersson, Médea Padra, et al.. (2020). IL-36 Cytokines Promote Inflammation in the Lungs of Long-Term Smokers. American Journal of Respiratory Cell and Molecular Biology. 64(2). 173–182. 19 indexed citations
5.
Christenson, Karin, Anders Andersson, Lena Björkman, et al.. (2020). Increased CD11b and Decreased CD62L in Blood and Airway Neutrophils from Long-Term Smokers with and without COPD. Journal of Innate Immunity. 12(6). 480–489. 16 indexed citations
6.
Torén, Kjell, Paul D. Blanc, Rajen N. Naidoo, et al.. (2019). Occupational exposure to dust and to fumes, work as a welder and invasive pneumococcal disease risk. Occupational and Environmental Medicine. 77(2). 57–63. 27 indexed citations
7.
Torén, Kjell, Paul D. Blanc, Rajen N. Naidoo, et al.. (2019). Occupational Exposure to Dust and to Fumes, Work As a Welder and Invasive Pneumococcal Disease Risk. SSRN Electronic Journal. 2 indexed citations
8.
Tengvall, Sara, et al.. (2017). Endotoxin Exposure Increases LL-37 - but Not Calprotectin - in Healthy Human Airways. Journal of Innate Immunity. 9(5). 475–482. 5 indexed citations
9.
Lindén, Anders, Sara Tengvall, Anders Andersson, et al.. (2015). Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization?. International Journal of COPD. 10. 689–689. 16 indexed citations
10.
Tengvall, Sara, Bettina Levänen, Max Vikström, et al.. (2014). Interleukin-26 in Antibacterial Host Defense of Human Lungs. Effects on Neutrophil Mobilization. American Journal of Respiratory and Critical Care Medicine. 190(9). 1022–1031. 61 indexed citations
11.
Torén, Kjell, Ingemar Qvarfordt, Ingvar A. Bergdahl, & Bengt Järvholm. (2011). Increased mortality from infectious pneumonia after occupational exposure to inorganic dust, metal fumes and chemicals. Thorax. 66(11). 992–996. 43 indexed citations
12.
Andersson, Anders, Apostolos Bossios, Carina Malmhäll, et al.. (2010). Effects of tobacco smoke on IL-16 in CD8+cells from human airways and blood: a key role for oxygen free radicals?. American Journal of Physiology-Lung Cellular and Molecular Physiology. 300(1). L43–L55. 8 indexed citations
13.
Glader, Pernilla, Steven Bozinovski, Margareta Sjöstrand, et al.. (2008). Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space. European Respiratory Journal. 32(3). 644–650. 9 indexed citations
14.
Didon, Lukas, Ingemar Qvarfordt, Olof Andersson, Magnus Nord, & Gerdt C. Riise. (2005). Decreased CCAAT/Enhancer Binding Protein Transcription Factor Activity in Chronic Bronchitis and COPD. CHEST Journal. 127(4). 1341–1346. 19 indexed citations
15.
Åndersson, Bengt, et al.. (2003). Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels. Respiratory Medicine. 98(2). 108–114. 10 indexed citations
17.
Qvarfordt, Ingemar, et al.. (2000). Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations. Respiratory Medicine. 94(9). 881–887. 23 indexed citations
19.
Qvarfordt, Ingemar, et al.. (1998). Immunological findings in blood and bronchoalveolar lavage fluid in chronic bronchitis patients with recurrent infectious exacerbations. European Respiratory Journal. 11(1). 46–54. 17 indexed citations
20.
Kaufman, Lee D., Gail M. Kephart, Roberta Seidman, et al.. (1993). The spectrum of eosinophilic myositis. Arthritis & Rheumatism. 36(7). 1014–1024. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026